Our experts in health economics, value communication, design and digital discussed how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams...
Read More
What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this...
Read More
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? What does the ‘2022/23 priorities and operational planning guidance’ document...
Read More
Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how...
Read More
What is a Place in the new NHS structure? What role will Place leaders have in decision-making? What will this new structure mean for the way Pharma and Medtech engage...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what...
Read More
How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits...
Read More
How can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the...
Read More
What role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up...
Read More
